Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...

The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the popular drug and an eye condition called NAION.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The lawsuits allege that Ozempic causes a rare eye condition called NAION, or non-arteritic anterior ischemic optic neuropathy, which is akin to an eye stroke. All but one of the cases were filed ...